Clinical Trial Update: Single Dose Escalation Study in Patients With Chronic Heart Failure [Phase 1]

View source ↗

Summary

Bayer sponsors a Phase 1 single-dose escalation trial in patients with chronic heart failure, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Bayer | Conditions: Heart Failure | Phase 1 | Status: COMPLETED